Monitoring Lipolysis by Sensing Breath Acetone down to Parts-per-Billion

Mobile health technologies can provide information routinely and on demand to manage metabolic diseases (e.g., diabetes and obesity) and optimize their treatment (e.g., exercise or dieting). Most promising is breath acetone monitoring to track lipolysis and complement standard glucose monitoring. Yet, accurate quantification of acetone down to parts-per-billion (ppb) is difficult with compact and mobile devices in the presence of interferants at comparable or higher concentrations. Herein, a low-cost detector that quantifies end-tidal acetone during exercise and rest is presented with excellent bias (25ppb) and unprecedented precision (169ppb) in 146 breath samples. It combines a flame-made Pt/Al2O3 catalyst with a chemoresistive Si/WO3 sensor. The detector is robust against orders of magnitude higher ethanol concentrations from disinfection and exercise-driven endogenous breath isoprene ones, as validated by mass spectrometry. This detector accurately tracks the individual lipolysis dynamics in all volunteers, as confirmed by blood ketone measurements. It can be integrated readily into handheld devices for personalized metabolic assessment at home, in gyms, and clinics.

Automated summary

Mobile health technologies offer new possibilities for managing metabolic diseases, with breath acetone monitoring showing potential for personalized treatments. A low-cost detector has been developed to accurately track lipolysis dynamics, suitable for metabolic assessment in various settings.